Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 14 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ambrisentan (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬1. Ambrisentan
| [1] EDNRA EDNRA 💬1. Ambrisentan
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [7] 51 51, 84, 85, 86, 88, 210, 211 💬
| ||||||||||||
| 2 | Ambrisentan - high dose (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬2. Ambrisentan - high dose
| [1] EDNRA EDNRA 💬2. Ambrisentan - high dose
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 86 86 💬2. Ambrisentan - high dose
| ||||||||||||
| 3 | Ambrisentan - low dose (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬3. Ambrisentan - low dose
| [1] EDNRA EDNRA 💬3. Ambrisentan - low dose
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 86 86 💬3. Ambrisentan - low dose
| ||||||||||||
| 4 | Ambrisentan 5 mg (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬4. Ambrisentan 5 mg
| [1] EDNRA EDNRA 💬4. Ambrisentan 5 mg
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 88 88 💬4. Ambrisentan 5 mg
| ||||||||||||
| 5 | Ambrisentan 5 mg film-coated tablets (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬5. Ambrisentan 5 mg film-coated tablets
| [1] EDNRA EDNRA 💬5. Ambrisentan 5 mg film-coated tablets
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 86 86 💬5. Ambrisentan 5 mg film-coated tablets
| ||||||||||||
| 6 | Ambrisentan 5mg film-coated tablets [marketed product] (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| [1] EDNRA EDNRA 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 86 86 💬6. Ambrisentan 5mg film-coated tablets [marketed product]
| ||||||||||||
| 7 | Ambrisentan plus Spironolactone (Letairis (TN)) | [2] Ambrisentan Ambrisentan (Letairis),Spironolactone | [2] Spironolactone
Spironolactone
,Ambrisentan (Letairis (TN)) 💬 7. Ambrisentan plus Spironolactone
| [2] EDNRA EDNRA,NR3C2 💬 | [8] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-recepto ... | [1] 86 86 💬7. Ambrisentan plus Spironolactone
| ||||||||||||
| 8 | Ambrisentan Tablet (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬8. Ambrisentan Tablet
| [1] EDNRA EDNRA 💬8. Ambrisentan Tablet
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 86 86 💬8. Ambrisentan Tablet
| ||||||||||||
| 9 | Bosentan, Ambrisentan (Letairis (TN)) | [2] Ambrisentan Ambrisentan (Letairis),Bosentan | [3] Bosentan
Bosentan
,Ambrisentan (Letairis (TN)), Bosentan 💬 9. Bosentan, Ambrisentan
| [2] EDNRA EDNRA,EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | [1] 86 86 💬9. Bosentan, Ambrisentan
| ||||||||||||
| 10 | Letairis | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬10. Letairis
| [1] EDNRA EDNRA 💬10. Letairis
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [1] 85 85 💬10. Letairis
|